Genmab — Maj 2023
-
@Bongobob: fra Janine Schuurman LinkedIn profil i januar 23: Dear friends and colleagues,
after >22 years at Genmab I have decided it is time for my #Genmab chapter to come to an end, it is time for a change.
-
Ja, procentregning er taknemmelig: Aridis lå 29.7.2022 i kurs 2,47 - efterfølgende faldet til kurs 0,185 - og er nu steget til kurs 0,33.

-
Nyt fase 3 med Mim8: https://clinicaltrials.gov/ct2/show/NCT05878938?term=mim8&draw=2&rank=3
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind